Michael Kaufman
2021
Compensation breakdown
Option Awards | $1,656,619 |
---|---|
Salary | $286,180 |
Stock Awards | $527,250 |
Other | $40,988 |
Total | $2,511,036 |
Kaufman received $1.7M in option awards, accounting for 66% of the total pay in 2021.
Kaufman also received $286.2K in salary, $527.3K in stock awards and $41K in other compensation.
Rankings
In 2021, Michael Kaufman's compensation ranked 5,136th out of 12,415 executives tracked by ExecPay. In other words, Kaufman earned more than 58.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,136 | 59th |
Manufacturing | 2,160 | 61st |
Chemicals And Allied Products | 929 | 61st |
Drugs | 830 | 60th |
Pharmaceutical Preparations | 594 | 62nd |
Pay ratio
Michael Kaufman's Pay | $2,511,036 |
---|---|
Median Employee's Pay | $302,642 |
Pay Ratio | 8to 1 |
In 2021, the annual total compensation of Michael Kaufman was $2,511,036.
The annual total compensation of the median employee at Mersana Therapeutics was $302,642.
The ratio of Michael Kaufman's pay to the pay of median employee was therefore 8 to one.
Kaufman's colleagues
We found six more compensation records of executives who worked with Michael Kaufman at Mersana Therapeutics in 2021.
2021
Anna Protopapas
Mersana Therapeutics
Chief Executive Officer
2021
Timothy Lowinger
Mersana Therapeutics
Senior Vice President, Chief Science and Technology Officer
2021
Brian DeSchuytner
Mersana Therapeutics
Chief Financial Officer
2021
Alejandra Carvajal
Mersana Therapeutics
Chief Legal Officer
2021
Tushar Misra
Mersana Therapeutics
Senior Vice President, Chief Manufacturing Officer
2021
Arvin Yang
Mersana Therapeutics
Chief Medical Officer
News
April 29, 2022
April 27, 2021
April 20, 2020
April 23, 2019